Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
951 studies found for:    CB2
Show Display Options
Rank Status Study
1 Completed A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis
Condition: Osteoarthritis
Intervention: Drug: GW842166
2 Completed An Imaging Study to Investigate the Distribution of GW842166X in the Brain.
Conditions: Analgesia;   Inflammation;   Pain, Inflammatory
Intervention: Drug: GW842166X
3 Completed Dental Pain 3rd Molar Tooth Extraction GW842166
Condition: Pain
Intervention: Drug: GW842166
4 Completed Cabergoline Reduces OHSS
Condition: Ovarian Hyperstimulation Syndrome
Interventions: Drug: Cabergoline;   Procedure: MR;   Procedure: Ultrasound;   Procedure: Blood Analysis
5 Unknown  Supplementation of Lycopene in Carotid Atheroma
Condition: Carotid Atherosclerotic Disease
Interventions: Drug: Placebo;   Dietary Supplement: Ateronon
6 Unknown  Lycopene Following Aneurysmal Subarachnoid Haemorrhage
Conditions: Subarachnoid Hemorrhage;   Aneurysm
Interventions: Drug: Lycopene;   Drug: placebo
7 Terminated Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.
Condition: Healthy Subjects
Intervention: Drug: GW842166X
8 Completed A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: 50 mg S-777469;   Drug: 200 mg S-777469;   Drug: 800 mg S-777469;   Drug: Placebo
9 Unknown  Use of Cannabinoids in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Sativex
10 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
11 Unknown  Cannabis for Inflammatory Bowel Disease
Conditions: Crohn's Disease;   Ulcerative Colitis
Interventions: Drug: smoking of cannabis;   Drug: smoking cigarettes with placebo
12 Recruiting The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain
Condition: Chest Pain
Interventions: Drug: Marinol;   Drug: Placebo
13 Unknown  Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain
Condition: Diabetic Neuropathies
Intervention: Drug: Nabilone, flexible dosing
14 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
15 Recruiting ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
Conditions: Lymphoma, Large-Cell, Anaplastic;   Lymphoma, Non-Hodgkin;   Lymphoma, T-Cell
Interventions: Drug: brentuximab vedotin;   Drug: doxorubicin;   Drug: prednisone;   Drug: vincristine;   Drug: cyclophosphamide
16 Recruiting B0151005 Open-Label Extension Study
Condition: Crohn's Disease
Intervention: Biological: PF-04236921
17 Recruiting A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour
Condition: Haemorrhage
Intervention: Device: Inhalation profile recorder
18 Recruiting Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: CP-690,550
19 Completed
Has Results
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Goserelin;   Drug: Bicalutamide
20 Completed A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: GSK1614235;   Drug: Sitagliptin;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years